JAKARTA, Nov 5 (Xinhua): Indonesia's food and drug authority BPOM has approved the emergency use authorisation for the Inavac Covid-19 vaccine as primary for the age group of 18 years and above.
"Considering security aspects and efficacy, the Inavac vaccine has been approved for active immunization for Covid-19 prevention in individuals aged 18 years and above," BPOM chief Penny K. Lukito told a virtual press conference on Friday.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
